Genmab — Oktober 2020
-
Bloomberg - kan ikke linke
-
-
https://finance.yahoo.com/news/astellas-seagen-announce-positive-topline-104500710.html Seagen (Seattle Genetics) med gode data.
-
EMA agenda this week, Day 180 list of outstanding issues: 3.2.15. ofatumumab - EMEA/H/C/005410
treatment of relapsing forms of multiple sclerosis.
Scope: List of outstanding issues
Action: For adoption
List of Questions adopted on 28.05.2020. https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-agenda-12-15-october-2020-meeting_en.pdf -
2402
-
Kursgraf: På grund af stor tyngde i health
care i det danske aktieindeks, kan der være en meget positiv periode forude for danske aktier....https://www.proinvestor.com/investornyt/668488/stoxx-der-kom-kobssignalet-i-europaeiske-health-care -
Genmab/Morgan Stanley: Kursmål hæves til 2180 kr. fra 2017 kr.https://www.proinvestor.com/investornyt/668493/genmab-morgan-stanley-kursmal-haeves-til-2180-kr-fra-2017-kr
-
Jeg så en på S A, der havde et mere lyst syn på Gmab. Måske en 10-bagger,, den er næsten doblet, siden han skrev om den sidst for et år siden. Nu skal man ikke lægge en hel masse i et enkelt skriv på S A, Nogle gange er det ren underholdning, der er i hvert fald vild uenighed blandt deres skr
ibenter. -
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind